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Joël CosteID
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Given the increasing burden of chronic conditions, multimorbidity is now a priority for health-
care and public health systems worldwide. Appropriate methodological approaches for
assessing the phenomenon have not yet been established, resulting in inconsistent and
incomplete descriptions. We aimed to estimate and characterize the burden of multimorbid-
ity in the adult population in France in terms of number and type of conditions, type of under-
lying mechanisms, and analysis of the joint effects for identifying combinations with the most
deleterious interaction effects on health status.
Methods and findings
We used a multistep approach to analyze cross-sectional and longitudinal data from 2 large
nationwide representative surveys: 2010/2014 waves of the Health, Health Care, and Insur-
ance Survey (ESPS 2010–2014) and Disability Healthcare Household Survey 2008 (HSM
2008), that collected similar data on 61 chronic or recurrent conditions. Adults aged�25
years in either ESPS 2010 (14,875) or HSM 2008 (23,348) were considered (participation
rates were 65% and 62%, respectively). Longitudinal analyses included 7,438 participants
of ESPS 2010 with follow-up for mortality (97%) of whom 3,798 were reinterviewed in 2014
(52%). Mortality, activity limitation, self-reported health, difficulties in activities/instrumental
activities of daily living, and Medical Outcomes Study Short-Form 12-Item Health Survey
were the health status measures. Multiple regression models were used to estimate the
impact of chronic or recurrent conditions and multimorbid associations (dyads, triads, and
tetrads) on health status. Etiological pathways explaining associations were investigated,
and joint effects and interactions between conditions on health status measures were evalu-
ated using both additive and multiplicative scales.
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Forty-eight chronic or recurrent conditions had an independent impact on mortality, activ-
ity limitations, or perceived heath. Multimorbidity prevalence varied between 30% (1-year
time frame) and 39% (lifetime frame), and more markedly according to sex (higher in
women), age (with greatest increases in middle-aged), and socioeconomic status (higher in
less educated and low-income individuals and manual workers). We identified various multi-
morbid combinations, mostly involving vasculometabolic and musculoskeletal conditions
and mental disorders, which could be explained by direct causation, shared or associated
risk factors, or less frequently, confounding or chance. Combinations with the highest health
impacts included diseases with complications but also associations of conditions affecting
systems involved in locomotion and sensorial functions (impact on activity limitations), and
associations including mental disorders (impact on perceived health). The interaction effects
of the associated conditions varied on a continuum from subadditive and additive (associa-
tions involving cardiometabolic conditions, low back pain, osteoporosis, injury sequelae,
depression, and anxiety) to multiplicative and supermultiplicative (associations involving
obesity, chronic obstructive pulmonary disease, migraine, and certain osteoarticular pathol-
ogies). Study limitations included self-reported information on chronic conditions and the
insufficient power of some analyses.
Conclusions
Multimorbidity assessments should move beyond simply counting conditions and take into
account the variable impacts on health status, etiological pathways, and joint effects of
associated conditions. In particular, the multimorbid combinations with substantial health
impacts or shared risk factors deserve closer attention. Our findings also suggest that multi-
morbidity assessment and management may be beneficial already in midlife and probably
earlier in disadvantaged groups.
Author summary
Why was this study done?
• The growing burden of chronic conditions has made multimorbidity a priority for
healthcare and public health systems worldwide.
• Over the past 2 decades, multimorbidity has been increasingly investigated in various
settings and populations, but the large variations in estimates can partly be attributed to
the heterogeneity of settings, designs, and analytical methods.
• The impact and joint effects of the most frequently associated chronic or recurrent con-
ditions on health have not yet been quantified, and the underlying mechanisms explain-
ing these associations have been seldom explored.
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interval; COPD, chronic obstructive pulmonary
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What did the researchers do and find?
• A comprehensive and multistep analysis of 2 large nationwide representative surveys
allowed the estimation and characterization of the burden of multimorbidity in the gen-
eral population in France.
• This study clarified several issues regarding the assessment and measurement of multi-
morbidity, notably in terms of the number and type of conditions to be considered, the
type of underlying mechanisms to explain the associations, and the analysis of the joint
effects of associated conditions to identify those with most deleterious interaction effects
on health.
What do these findings mean?
• Multimorbidity assessments should move beyond simply counting chronic conditions
and include a wide spectrum of chronic conditions. They should especially consider the
variable impacts and joint effects of associated conditions.
• Multimorbid combinations with large health impacts or multiplicative interactions
should also be appropriately prioritized for monitoring and management. As multimor-
bidity does not only affect older people, its assessment and management should begin in
midlife and probably earlier in disadvantaged groups.
Introduction
The gains in life expectancy observed worldwide have increased the risk of living with chronic
conditions [1]. Over the past 2 decades, multimorbidity, defined as the co-occurrence of at
least 2 chronic or recurrent conditions [2], has been increasingly investigated and estimated in
various populations, settings, and geographical locations [3–6]. The broad variations observed
in the available estimates of the burden of multimorbidity can be attributed, at least partly, to
heterogeneous study methodologies in terms of the number and type of conditions (e.g., dis-
eases, risk factors, symptoms, specific conditions) as well as the thresholds used (e.g., two or
three) [7,8]. In particular, the identification of conditions for inclusion in multimorbidity
assessments has largely relied on the prevalence, or more commonly, the availability of condi-
tions in existing datasets [8]. The type and meaning of multimorbid associations have subse-
quently received attention [9], although the etiological pathways have seldom been explored
[10]. Significantly, the quantified impact of multimorbid associations on relevant health indi-
cators such as mortality or limitations in daily activities has scarcely been estimated [11,12].
Furthermore, the metrics of the joint effects of the associated conditions (i.e., additive or mul-
tiplicative scale), which is a critical issue for measuring multimorbidity, has been largely
ignored.
To address this gap, we aimed to estimate and characterize the burden of multimorbidity in
the French general population using a comprehensive and multistep analytical approach in
order to (1) identify the relevant chronic or recurrent conditions for inclusion in multimorbid-
ity assessments based on their impact on health status; (2) determine the frequency of the co-
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occurrence of these conditions and their underlying etiological pathways; and (3) evaluate the
impact of the number of conditions and their associations as well as the joint effects of associ-
ated conditions on health. This study further aimed to contribute to our knowledge of multi-
morbidity in France where general population studies are rare [6].
Materials and methods
Survey designs and study populations
We used data from 2 large nationwide representative surveys conducted in France between
2008 and 2014, which used similar interview and sampling methods as well as similar lists of
chronic conditions and health indicators: the Health, Health Care, and Insurance Survey from
2010 and 2014 (Enquête Santé et Protection Sociale, ESPS) and the Disability Healthcare
Household Survey from 2008 (Enquête Handicap–Santé Ménages, HSM). Despite several dif-
ferences, notably in terms of the time frame used to investigate morbidities that prevented
cross-validation or replication in the strictest sense, there was sufficient commonality between
the studies to look for convergent evidence based on their parallel analyses.
ESPS is a longitudinal health survey representative of individuals living in households in
France (95% of the total population). It collects information about their health status through
telephone and face-to-face interviews conducted by specially trained interviewers as well as
self-administered questionnaires [13]. In 2010, the participation rate was 65%, resulting in
14,875 participants aged�25 years. Half of participants (N = 7,727, one per household) were
scheduled to be followed-up to be reinterviewed regarding health status measures in 2014.
Linkage with vital statistics, for these participants only, also allowed for the assessment of mor-
tality up to and including 2014.
HSM is a purely cross-sectional two-stage survey conducted in 2008 with a focus on health,
disability, and dependency. The participation rates for the first stage to screen individuals with
disabilities and the second stage were 80% and 77%, respectively, leading to 23,348 participants
aged�25 years residing in France being evaluated in face-to-face interviews and self-adminis-
tered questionnaires in the second stage [14].
Both HSM 2008 and ESPS 2010–2014 received institutional review board approval, and
participants provided written informed consent.
Chronic and recurrent conditions
Both surveys used similar interviews and questionnaires, although there were minor variations
in the lists and labels of self-reported conditions. A total of 61 chronic or recurrent conditions
were recorded, which is at the top end of the range (25 to 75) recommended by Holzer and col-
leagues for multimorbidy assessement [15]. This list included conditions typically found in
previous multimorbidity studies [15] (Table 1). The ESPS survey considered conditions occur-
ring within the past 1-year period, whereas the HSM survey considered lifetime occurrence.
Both time frames are relevant, as several conditions have lifelong implications (e.g., cancer,
vascular diseases), while others have more temporary effects (e.g., depression, asthma) [5].
Health status measures
In addition to the mortality recorded in the ESPS survey, several measurements relating to
functioning and perceived health were taken into account using valid and reliable instruments.
Both surveys included the European Union Global Activity Limitation Indicator (GALI; extent
to which the participant is limited because of a health problem in their daily activities: severely
limited/limited but not severely/not limited at all) and Self-Reported Health (SRH; how the
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participant evaluates his/her general health: very good/good/fair/bad/very bad) [16]. Difficul-
ties in activities of daily living (ADL, N = 7) [17], instrumental activities of daily living (IADL,
N = 12) [18], and the Medical Outcomes Study Short-Form 12-Item Health Survey (SF-12)
questionnaire were only included in the HSM survey [19]. Change scores were calculated for
functioning and perceived health measures in ESPS participants when repeated measurements
were available (GALI, SRH). Fig 1 presents the conceptual model assumed in this study. In line
with a large body of research in the field of disability and perceived health and quality of life
[20–22], the pathological processes were considered to cause disability and nonoptimal health;
age, sex, and socioeconomic status were considered to be the determinants of morbid condi-
tions, disability, and nonoptimal health. Under this model, it is possible to evaluate and quan-
tify the impacts of morbid conditions on health status.
Statistical analysis
We implemented a sequential multistep analytical approach to (1) identify the relevant condi-
tions for inclusion in the multimorbidity analysis; (2) determine the frequency and type of
associations of conditions identified as relevant; and (3) estimate the impact of these multi-
morbid associations on health status.
Identifying the relevant conditions associated with impacts on health status. We
aimed to select conditions that were consistently associated with independent impacts on
health status across surveys and/or within surveys across indicators (functioning, perceived
health, mortality) and across thresholds in the case of categorical indicators (see below). Multi-
ple regression models were used to assess the independent effects on health status measures of
each recorded condition adjusted for age and sex: binary logistic regression for mortality, new
limitation in GALI, and health deterioration in SRH; polytomous logistic regression for cate-
gorical indicators in GALI (two thresholds: any and only severe limitation), SRH (two thresh-
olds: “fair health” and “good health”), and ADL-IADL (two thresholds: any and limitation in
�3 ADLs or�2 IADLs); and linear regression for SF-12 summary scores. As recommended
for over a decade [23–25], lasso methods were used to select the conditions to be retained in
the final models. Interactions with age and sex were tested for each condition included in the
final models. We also compared the explanatory power of the raw count of included condi-
tions relative to the inclusion of binary indicators for all conditions; we used restricted cubic
splines to model nonlinear relationships between the count and the health status measures
using 5 knots: 2, 3, 4, 6, and 9, respectively, located at the 35 or 50th, 60 or 70th, 88th, 95th,
and 99th percentiles of the number of morbidities according to the study.
Determining the frequency and type of associated conditions. We described the fre-
quency of dyads, triads, and tetrads of the associated conditions retained in the previous step
and investigated the etiological pathways that most plausibly explain the most frequent
Fig 1. Schematic diagram of the conceptual model assumed in this study.
https://doi.org/10.1371/journal.pmed.1003584.g001
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associations (�0.25%) using the typology by Valderas and colleagues [10] who retained 5 path-
ways: direct causation, shared risk factors, associated risk factors, confounding by another con-
dition, and only chance (Fig 2). This categorization was practically implemented in a
standardized way, through the following steps:
i. The age- and sex-adjusted odds ratio (OR) for the dyad and the fully adjusted OR, including
all conditions independently associated with both components of the dyad, were computed
using binary logistic models (with the first component of the dyad as the dependent vari-
able). If the 95% confidence interval (CI) of the age- and sex-adjusted OR included 1, we
considered that the dyad could be “explained by chance.” If the 95% CI of the age- and sex-
adjusted OR did not include 1, while the 95% CI of the fully adjusted OR included 1, we
considered that the dyad could be explained by confounding by another condition. These
analyses were conducted in both ESPS and HSM surveys.
ii. When the 95% CI of the fully adjusted OR for the dyad did not include 1 (independent
association) in both surveys, a thorough literature search was performed by one of us (JC)
on MEDLINE and Google Scholar search engines using the following terms: “association,”
“cause,” “determinant,” “complication,” “risk factor,” or “epidemiology” along with each
component of the dyad. Systematic reviews as well as primary studies were considered. If a
reasonable consensus was found in the literature regarding a causal link between the condi-
tions, we considered that the dyad could be explained by a causal relationship. We subse-
quently specified whether this relation was bidirectional or due to a complication.
Otherwise, if there was a reasonable consensus regarding the shared risk factors, we consid-
ered that the dyad could be explained by “shared risk factors” and thus mentioned them.
Otherwise, if there was a reasonable consensus regarding the association of risk factors, we
considered that the dyad could be explained by “associated risk factors” and thus men-
tioned them. Several exceptions were made to this categorization to indicate “strongly
related pathological processes” such as hip and knee osteoarthritis, ischemic heart disease
and peripheral arterial disease (atherosclerosis), or anxiety and depression.
Estimating the impact and joint effects of multimorbid associations. We described the
health impacts of dyads, triads, and tetrads of associated conditions on activities, perceived
health, and mortality. Following VanderWeele [26], the joint effects of multimorbid associa-
tions were conceptualized as the sum of the effects of each condition and their interaction,
with the latter considered on a continuum ranging from subadditive (negative additive inter-
action) to supermultiplicative (positive multiplicative interaction). The placement on the con-
tinuum depended on the relative magnitude of the probability of negative health status in the
group in terms of the associated conditions: Associations at the (super)multiplicative end are
associated with worse health status than those at the (sub)additive end (Fig 3).
Fig 2. Typology of etiological associations between comorbid conditions.
https://doi.org/10.1371/journal.pmed.1003584.g002
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Joint effects and interactions of associated conditions on functioning (severely limited in
GALI; limited in�3 ADLs or�2 IADLs; new limitation) and perceived health (bad or very
bad; health deterioration) were thus evaluated on both additive and multiplicative scales by esti-
mating the relative excess risk due to interaction (RERI) [27] and the ratio of odds ratios
(RoOR) in the logistic models, including the associations of conditions, age, sex, and all the con-
ditions independently associated with the predicted health indicator as identified in the first
step. Due to a limited number of events, it was not possible to study the joints effects on mortal-
ity. To ensure that the RoOR and RERI estimates (based on the ORs) were valid, joint-effect
analyses were only conducted for health indicators with a prevalence�10% (the ORs approxi-
mate the relative risks in this context). CIs of RERI were computed according to Zou [28].
All the analyses (descriptive and analytic) were performed separately for the 2 surveys using
SAS, version 9.2 software (SAS Institute, Cary, NC, USA) and R software, version 3.6.1 (lasso
methods). Appropriate weights were used to provide valid estimates for the French population,
while taking into account the unequal probabilities of selection resulting from sample design,
nonresponse, and noncoverage in the 2 surveys [13,14]. Due to the data collection methodol-
ogy used (mostly personal interviews in the 2 surveys), there were very few missing data
(<0.005) either for conditions, standard sociodemographic variables, or health status mea-
sures. Due to the complex sampling designs, however, classical standard goodness of fit and
predictive ability statistics including the Hosmer–Lemeshow statistic and c-index were not
available. The Akaike information criterion (AIC) was used for model comparison.
The main analyses were planned before being conducted. Further analyses were only per-
formed to respond to the reviewers’ comments, notably regarding the characteristics of ESPS
participants in the longitudinal analyses and the risk of multimorbidity associated with socio-
demographic variables, with no influence on the main findings. No data-driven changes were
made to the analyses.
This study is reported in line with the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) guidelines (S1 STROBE Checklist).
Results
All 14,875 ESPS and 23,348 HSM participants aged�25 were included in the cross-sectional
analyses. Nearly half of the ESPS sample (N = 7,438, 97% of scheduled participants) was fol-
lowed up for mortality until 2014, when 3,798 (52%) agreed to participate again in the survey
for longitudinal analyses. A description of the 4 analyzed samples is given in S1 Table. There
were no important differences between them.
Chronic or recurrent conditions with a negative impact on health status
Overall, 48 out of 61 recorded chronic or recurrent conditions consistently affected activity
limitations, perceived health, or mortality (Table 1 and S2 Table). The remaining conditions
Fig 3. Interaction continuum and 5 categories of interaction on additive and multiplicative scales considered in
this study. RoOR, ratio of odds ratios; RERI, relative excess risk due to interaction.
https://doi.org/10.1371/journal.pmed.1003584.g003
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were not associated with any of the health status measures, with the exception of nutritional
anemias, which had an inconsistent impact on GALI. There was no interaction of sex with any
assessed risk. An interaction of age was observed for low back pain, depression, and injury
sequelae: Younger participants with these conditions had a higher risk of limitations or bad
health than older ones. S3 Table details the impact of the studied chronic conditions on func-
tioning and perceived health within the 2 reference time frames (1-year versus lifetime).
Although generally similar, the proportion of participants reporting more severe impacts
tended to be higher within the lifetime frame (a difference not explained by the age of the
affected participants).
The raw count of these 48 conditions was associated with all health status measures (except
mortality), although it was less informative than the separate inclusion of all the conditions
(AIC 5% to 10% higher than those obtained with the final models). Moreover, the changes in
slope (negative) observed for all indicators except for one at 3 and 6 conditions in spline
regressions suggest that the health impacts rapidly stabilize, probably due to ceiling effects,
when using this count (see below).
Prevalence of, and factors associated with multimorbidity
Overall, multimorbidity was observed in 30.4% of participants (95% CI: 29.6% to 31.3%) using
the 1-year time frame of the ESPS survey and 39.0% (95% CI: 38.0% to 40.0%) using the life-
time frame of the HSM survey (Table 2). Regardless of the time frame, the prevalence of multi-
morbidity increased almost linearly with age and was higher in women than in men: Using the
1-year time frame, it ranged from 7% among 25- to 34-year-old men to 67% among women
Table 2. Weighted frequency of multimorbidity, defined as having at least 2 of the 48 selected conditions, analyzed according to age, sex, and 3 socioeconomic status
indicators (education level, occupation, and household income). Conditions present during the last 12 months (ESPS Survey) and lifetime presence (HSM Survey).
1-year time frame (ESPS Survey)/Lifetime frame (HSM Survey)
25–34 y 35–44 y 45–54 y 55–64 y 65–74 y 75–84 y �85 y
Men All 7.1/12.2 10.9/20.0 18.2/31.9 36.7/45.5 51.0/63.1 66.2/68.7 62.4/78.3
Less than secondary education 5.9/17.0 11.7/28.8 20.6/37.6 37.8/51.1 53.5/66.1 63.3/72.1 62.7/75.6
Secondary education 7.7/13.3 12.3/20.8 19.1/33.2 37.8/44.6 48.0/62.0 74.6/66.5 53.1/88.6
Tertiary education 6.7/9.6 8.6/13.2 13.1/22.8 32.5/37.7 51.0/55.6 67.1/NC 85.0/NC
Occupation, other or manual worker 7.5/15.2 10.3/23.7 18.8/35.4 39.2/50.7 51.5/68.2 64.0/69.5 56.9/76.0
Occupation, middle manager or teacher 4.9/9.5 15.1/21.5 19.3/30.5 35.2/45.0 49.5/61.9 75.7/70.7 83.2/87.5
Occupation, manager or professional 9.1/9.3 5.8/9.9 14.8/25.8 33.2/36.9 52.7/53.9 65.6/62.7 65.7/75.6
Household income, lower third 8.3/15.2 20.5/25.0 28.7/39.5 47.1/54.2 61.7/67.6 70.6/69.0 75.4/80.8
Household income, middle third 7.4/12.4 12.4/20.9 21.8/32.3 51.6/44.8 62.7/65.1 79.3/72.6 76.5/70.8
Household income, upper third 8.9/10.9 10.9/16.5 20.1/28.5 38.3/38.8 60.0/60.9 80.6/62.6 NC/88.3
Women All 13.3/15.9 20.2/24.1 30.7/38.2 40.6/52.6 58.7/66.6 70.3/76.4 67.0/77.9
Less than secondary education 15.9/25.0 21.4/32.6 33.7/50.2 43.8/60.6 57.5/72.4 68.8/76.3 67.1/81.8
Secondary education 10.7/15.5 20.9/26.0 30.3/36.0 39.9/50.6 61.9/59.3 77.4/75.1 63.5/71.2
Tertiary education 15.9/14.4 18.8/17.9 27.2/30.3 33.7/39.8 57.0/55.3 73.2/85.5 74.4/NC
Occupation, other or manual worker 15.2/19.3 20.4/30.8 31.6/43.7 40.5/56.0 60.5/71.4 68.3/77.2 66.3/84.3
Occupation, middle manager or teacher 13.6/15.3 21.5/22.2 31.3/36.9 43.4/54.1 59.3/64.9 71.8/75.7 72.3/71.1
Occupation, manager or professional 8.0/12.2 15.7/10.5 23.1/26.0 32.2/38.1 53.3/54.2 81.1/NC 72.6/NC
Household income, lower third 21.4/19.7 29.7/32.2 50.7/48.4 54.6/61.8 74.0/68.6 79.0/77.7 79.6/81.2
Household income, middle third 15.6/13.6 28.2/23.9 38.6/34.6 46.9/51.4 71.7/65.9 80.9/80.2 80.3/78.2
Household income, upper third 11.1/16.8 20.0/20.2 30.8/36.5 48.2/44.0 66.2/64.9 82.8/78.3 NC/78.6
ESPS, Enquête Santé et Protection Sociale; HSM, Enquête Handicap–Santé Ménages; NC, estimation not calculated due to limited sample size.
https://doi.org/10.1371/journal.pmed.1003584.t002
PLOS MEDICINE Estimating and characterizing the burden of multimorbidity in the community
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003584 April 26, 2021 11 / 22
over 85 years. The greatest increases in prevalence were observed between the age groups of 45
to 54 and 55 to 64 years, and 55 to 64 and 65 to 74 years. Prevalence was also higher in less edu-
cated and low-income participants and manual workers, particularly in women and middle-
aged participants. Multiple logistic regression analyses confirmed the independent and “dose-
effect” associations of age, sex, education level, occupation, and household income with multi-
morbidity (S4 Table).
The vast majority of participants reporting multiple conditions had up to 4 conditions
(74% and 78% in the ESPS and HSM surveys, respectively) (S5 Table). The presence of 6 or
more concomitant conditions was uncommon before 75 years but was observed in one-quar-
ter of women after 85 years.
Regardless of participant age and survey time frame, about three-quarters of conditions
were more often observed in multimorbid combinations than alone, while 24 and 4 conditions
had a median of 2 and 3 associated conditions, respectively (S6 Table).
Associations of conditions and type of multimorbid combinations
The most frequent dyads (N = 223), triads and tetrads (N = 76) of chronic conditions along
with the plausible etiological pathways explaining their associations are presented in Table 3
and S7 and S8 Tables. The most frequent combinations include hypertension, low back pain,
obesity, osteoarthritis (knee, hip, or other peripheral joints), migraine, diabetes, anxiety,
depression, and ear ailments. Fig 4 summarizes the two-by-two independent associations
(dyads) between the 48 selected chronic conditions by visualizing 3 main aggregates of associa-
tions that are consistent across time frames: (i) vasculometabolic, including diseases of the cir-
culatory system, diabetes, and obesity; (ii) diseases of the musculoskeletal system; and (iii)
mental disorders. However, more scattered associations also exist, namely, anxiety and depres-
sion with various somatic conditions, especially musculoskeletal disorders, or the latter with
vasculometabolic conditions.
Overall, 44% of the most frequent two-by-two associations were found plausibly explicable
by direct causation, either unidirectional as in the case of a complication (e.g., myocardial
infarction and heart failure or hypertension and stroke) or bidirectional (e.g., osteoarthritis
and obesity or depression and migraine). Furthermore, 30% can be plausibly explained by
shared risk factors (e.g., chronic obstructive pulmonary disease (COPD) and ischemic heart
disease), or more rarely, by associated risk factors (e.g., cardiac rhythm disorders and low back
pain). Several associations (3%) may be explained by strongly related or similar pathological
processes (e.g., ischemic heart disease and myocardial infarction or hip and knee osteoarthri-
tis). Finally, for the remaining 23% of the associations, the co-occurrence of 2 conditions can,
after adjustment, be attributed to chance (e.g., hypertension and osteoporosis) or confounding
factors (e.g., heart failure and low back pain).
Impact and joint effects of associations between conditions (dyads and
triads)
The impact on health status varied greatly across the associated conditions (see S9 and S10
Tables for dyads and triads, respectively). With the exception of cardiovascular diseases com-
plicated by heart failure and inflammatory arthritis by osteoarthritis, the combinations with
the greatest impact on activities and general health frequently included conditions affecting
different bodily systems, notably circulatory or respiratory, musculoskeletal, and nervous.
Obesity, diabetes, eye and ear ailments, and mental disorders (especially depression) also con-
tributed to the associations with the most impact. These impacts were consistent across time
frames, although they were slightly greater in the lifetime frame.
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Interactions between the associated conditions on health status ranged from subadditive to
supermultiplicative (Fig 5 and S11 Table). Dyads with multiplicative or supermultiplicative
interactions included obesity, chronic obstructive pulmonary disease, migraine accompanying
other conditions, inflammatory arthritis and several forms of osteoarthritis, cardiac rhythm
disorders, and stroke; dyads with additive interactions included cardiometabolic conditions,
Table 3. Weighted frequency of dyads of conditions, strength of associations, and plausible etiological pathways explaining the associations. All dyads with a fre-
quency of�1% in both survey samples are considered. Dyads are presented in decreasing order of frequency (mean frequency based on the 2 surveys).
1-year time frame (ESPS Survey) Lifetime frame (HSM Survey)








Plausible etiological pathway(s) explaining the
association
Hypertension-Low back pain 3.63 2.23 (1.94–2.58) 1.60 (1.36–1.88) 3.73 1.53 (1.36–1.72) 1.44 (1.27–1.63) Shared determinants (obesity, smoking, mental)
Obesity, nonmorbid-Hypertension 3.40 4.22 (3.61–4.93) 2.98 (2.50–3.56) 3.50 2.49 (2.18–2.84) 2.24 (1.95–2.58) Causal (determinant)
Hypertension-Osteoarthritis of the knee 3.56 2.65 (2.25–3.12) 1.61 (1.33–1.94) 2.41 1.38 (1.20–1.59) 1.09 (0.95–1.27) Shared determinants (obesity, mental)
Osteoarthritis of the knee-Low back pain 3.03 4.03 (3.44–4.72) 2.63 (2.21–3.14) 2.88 2.42 (2.12–2.76) 1.67 (1.44–1.93) Shared determinants (obesity, mental)
Migraine-Low back pain 2.08 4.03 (3.40–4.76) 2.45 (2.02–2.99) 3.37 3.11 (2.70–3.57) 2.41 (2.07–2.81) Shared determinants (obesity, mental)
Osteoarthritis of other peripheral joints-Low back
pain
2.30 2.99 (2.52–3.55) 2.59 (2.16–3.11) 3.15 2.10 (1.84–2.40) 1.52 (1.31–1.76) Shared determinants (obesity, mental)
Hypertension-Osteoarthritis of other peripheral
joints
2.74 2.32 (1.94–2.78) 2.02 (1.67–2.44) 2.56 1.24 (1.08–1.42) 1.13 (0.98–1.30) Shared determinants (obesity, mental)
Anxiety-Low back pain 3.04 3.93 (3.39–4.56) 2.52 (2.12–3.00) 2.17 3.14 (2.69–3.67) 2.25 (1.91–2.65) Causal (bidirectional)
Diabetes-Hypertension 2.67 5.53 (4.46–6.85) 3.99 (3.19–4.98) 2.42 2.75 (2.35–3.21) 2.13 (1.82–2.51) Shared determinants (obesity)
Osteoarthritis of the knee-Osteoarthritis of other
peripheral joints
2.11 3.57 (2.94–4.33) 2.08 (1.67–2.60) 2.50 2.83 (2.43–3.29) 2.02 (1.72–2.38) Strongly related pathological processes
Osteoarthritis of the hip-Osteoarthritis of the knee 2.31 11.23 (8.99–14.02) 6.48 (5.10–8.25) 2.10 5.85 (4.94–6.92) 4.27 (3.60–5.06) Strongly related pathological processes
Obesity, nonmorbid-Low back pain 2.04 1.98 (1.70–2.32) 1.33 (1.11–1.60) 2.35 1.04 (0.91–1.18) - Causal (determinant)
Ear ailments-Hypertension 3.02 2.08 (1.76–2.47) 1.36 (1.12–1.65) 1.16 1.30 (1.07–1.57) 1.19 (0.98–1.44) Shared determinants (mental)
Depression-Anxiety 2.69 12.87 (10.65–15.56) 9.20 (7.45–11.37) 1.45 11.07 (9.13–13.42) 8.16 (6.61–10.06) Strongly related pathological processes
Obesity, nonmorbid-Osteoarthritis of the knee 1.97 3.49 (2.91–4.17) 2.33 (1.89–2.87) 2.09 2.48 (2.15–2.86) 2.43 (2.10–2.81) Causal (bidirectional)
Ear ailments-Low back pain 2.50 2.93 (2.49–3.45) 2.00 (1.68–2.40) 1.49 1.77 (1.49–2.11) 1.44 (1.19–1.74) Shared determinants (mental)
Osteoarthritis of the hip-Low back pain 1.81 4.62 (3.78–5.66) 2.24 (1.76–2.86) 2.09 3.03 (2.57–3.56) 2.16 (1.81–2.57) Shared determinants (obesity, mental)
Anxiety-Hypertension 2.51 2.17 (1.82–2.60) 1.57 (1.29–1.92) 1.35 1.61 (1.37–1.91) 1.39 (1.17–1.64) Causal (bidirectional)
Migraine-Anxiety 1.95 5.11 (4.26–6.13) 3.43 (2.81–4.18) 1.60 4.41 (3.71–5.24) 2.77 (2.28–3.38) Causal (bidirectional)
Hypertension-Osteoarthritis of the hip 1.97 2.63 (2.12–3.26) 1.42 (1.11–1.83) 1.52 1.31 (1.11–1.55) 1.17 (0.99–1.39) Shared determinants (obesity)
Cataract-Hypertension 1.84 2.19 (1.72–2.80) 1.88 (1.45–2.43) 1.64 1.11 (0.94–1.32) - Causal (determinant)
Diabetes-Obesity, nonmorbid 1.48 5.11 (4.14–6.30) 3.58 (2.85–4.49) 1.94 3.23 (2.76–3.76) 2.83 (2.40–3.33) Causal (determinant)
Hypertension-Cardiac rhythm disorders 2.18 3.34 (2.64–4.23) 2.68 (2.08–3.45) 1.05 1.91 (1.53–2.39) 1.62 (1.28–2.03) Causal (determinant)
Depression-Low back pain 1.68 3.12 (2.58–3.77) 1.43 (1.14–1.79) 1.50 2.62 (2.22–3.09) 1.64 (1.37–1.98) Causal (bidirectional)
Anxiety-Osteoarthritis of other peripheral joints 1.75 3.07 (2.54–3.72) 1.98 (1.59–2.42) 1.33 2.60 (2.17–3.12) 1.89 (1.56–2.29) Causal (bidirectional)
Anxiety-Osteoarthritis of the knee 1.92 3.11 (2.57–3.75) 1.71 (1.36–2.15) 1.08 2.44 (2.04–2.93) 1.50 (1.22–1.83) Causal (bidirectional)
Osteoarthritis of the hip-Osteoarthritis of other
peripheral joints
1.24 3.49 (2.73–4.46) 1.69 (1.26–2.26) 1.76 3.14 (2.61–3.79) 2.20 (1.81–2.68) Strongly related pathological processes
Thyroid disorders-Hypertension 1.57 2.37 (1.89–2.97) 1.79 (1.39–2.31) 1.39 1.70 (1.40–2.05) 1.49 (1.22–1.81) Causal (complication)
Obesity, nonmorbid-Osteoarthritis of other
peripheral joints
1.21 1.94 (1.57–2.39) 1.23 (0.96–1.57) 1.72 1.36 (1.18–1.58) 1.19 (1.03–1.39) Causal (determinant)
Thyroid disorders-Low back pain 1.13 1.92 (1.55–2.39) 1.32 (1.03–1.70) 1.57 1.91 (1.60–2.27) 1.53 (1.07–1.85) Causal (complication)
Migraine-Hypertension 1.10 1.70 (1.35–2.14) 1.11 (0.86–1.45) 1.52 1.28 (1.09–1.50) 1.07 (0.90–1.28) Confounding
Cataract-Low back pain 1.09 2.30 (1.81–2.93) 1.25 (0.95–1.64) 1.42 1.58 (1.32–1.88) 1.37 (1.14–1.64) Shared determinants (obesity, smoking)
Diabetes-Low back pain 1.04 1.58 (1.26–1.97) 1.12 (0.89–1.41) 1.35 1.10 (0.93–1.29) - Confounding
Cataract-Osteoarthritis of the knee 1.22 3.01 (2.34–3.88) 2.11 (1.60–2.78) 1.15 1.31 (1.09–1.59) 1.14 (0.94–1.39) Shared determinants (obesity)
Depression-Migraine 1.19 4.72 (3.79–5.88) 2.10 (1.63–2.72) 1.16 3.86 (3.23–4.63) 1.95 (1.59–2.40) Causal (bidirectional)
Cardiac rhythm disorders-Low back pain 1.25 2.29 (1.84–2.86) 1.49 (1.17–1.90) 1.03 2.04 (1.67–2.49) 1.48 (1.20–1.83) Associated determinants (obesity, vascular)
Migraine-Osteoarthritis of the knee 1.01 3.07 (2.44–3.87) 1.61 (1.23–2.11) 1.25 2.17 (1.84–2.56) 1.59 (1.32–1.90) Shared determinants (obesity, mental)
Diabetes-Osteoarthritis of the knee 1.12 2.16 (1.72–2.73) 1.23 (0.95–1.58) 1.08 1.57 (1.31–1.87) 1.20 (1.00–1.45) Confounding
COPD, chronic obstructive pulmonary disease; ESPS, Enquête Santé et Protection Sociale; HSM, Enquête Handicap–Santé Ménages; NT, not tested due to a limited
number of participants with the condition; OR, odds ratio.
�Full models include age-sex and all conditions associated independently with both components of the dyad (see Fig 1).
https://doi.org/10.1371/journal.pmed.1003584.t003
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musculoskeletal conditions, and injury sequelae with other conditions. Depression and anxiety
had a subadditive interaction: When associated with another condition, they had an additive
interaction. The patterns of effects were similar across time frames, although the interactions
shifted to the additive side for the lifetime frame compared to 1-year time frame (median
RERI shift of 0.68 and 0.31 for activity limitations and perceived health, respectively). The
same pattern of effects was observed within triads (S12 Table) where the joint effect of the
third condition with the other two was similar to when the condition was separately associated
with each of the other two.
Discussion
The use of a comprehensive and multistep analytical approach to analyze 2 large representative
general population samples with cross-sectional and longitudinal data on numerous chronic
Fig 4. Independent associations between the 48 selected chronic conditions. Associations were identified in logistic models built with forward and backward stepwise
procedures to identify the conditions independently associated with each condition while adjusting for age and sex. Upper right panel, above the diagonal: ESPS survey
and 1-year time frame; lower left panel, below the diagonal: HSM survey and lifetime frame. Obesity is categorized according to the standard BMI criteria (obese: BMI
30–35; morbidly obese: BMI>35) and analyzed as a 3-category variable. A light blue box indicates an OR�2. A star sign (�) indicates an OR between 2 and 4; 2 stars
(��) indicate an OR between 4 and 10; 3 stars (���) indicate an OR�10. An orange box indicates a negative association (OR<1). Frames indicate conditions within the
same ICD-10 chapter. BMI, body mass index; ESPS, Enquête Santé et Protection Sociale; HIV, human immunodeficiency virus; HSM, Enquête Handicap–Santé
Ménages; ICD-10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003584.g004
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conditions and a broad range of health indicators allowed us to estimate and characterize the
burden of multimorbidity in France. This study also makes novel contributions to 3 crucial
aspects of multimorbidity assessments and measurements: (1) proposing a comprehensive
method for estimating and characterizing the burden based on the health impacts; (2) deter-
mining the underlying mechanisms to explain the observed associations; and (3) identifying
multimorbid combinations with a high impact and the most deleterious interaction effects on
health.
Fig 5. Interactions between the associated conditions in dyads on activity limitations (severely limited in GALI, upper
right panel above the diagonal) and perceived health (bad or very bad SRH, lower left panel below the diagonal) in
ESPS (Panel A) and HSM surveys (Panel B). Interactions are evaluated by the RERI (see S8 Table for values) and
represented using a color scale from green (low values: subadditive or additive) to red (high values: multiplicative or
supermultiplicative). Only dyads with a frequency of�0.25% in at least 1 survey sample are considered. BMI, body
mass index; ESPS, Enquête Santé et Protection Sociale; GALI: Global Activity Limitation Indicator; HSM, Enquête
Handicap–Santé Ménages; RERI, relative excess risk due to interaction; SRH: Self-Reported Health indicator.
https://doi.org/10.1371/journal.pmed.1003584.g005
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Burden of multimorbidity in France
Our study is the first to characterize the burden of multimorbidity in France. Estimates of the
prevalence of specific conditions included in this study are similar to those previously reported
in this country [29], while estimates of the prevalence of multimorbidity and specific multi-
morbid combinations as well as the observed higher prevalence among women are in line with
other studies conducted in Europe [5,8] and worldwide [7]. Our study strongly confirms that
multimorbidity is not just a problem of old age [30–33]: In middle age (35 to 54 years), it
affects 1 in 6 men and 1 in 4 women. This study also found marked socioeconomic gradients,
with participants, especially women, with lower education and socioeconomic status exhibit-
ing higher multimorbidity rates earlier in the life, as already observed [5,34].
Estimating and characterizing the burden of multimorbidity
This study showed that a large number of chronic conditions (almost 50) significantly and
independently impact mortality, activity limitations, or perceived heath in adults. With the
exception of the Global Burden of Diseases (GBD) program, which included over 200 non-
communicable diseases in its 2017 updated version [1], most public health agencies worldwide
monitor much fewer chronic conditions. For example, the US Centers for Disease Control
monitors 10 conditions in the Behavioral Risk Factor Surveillance System [35], while Public
Health England generates prevalence estimates for 12 health problems according to “health
profiles,” to which modeled estimates of 7 conditions are added [36]. Until a consensus is
reached about which chronic conditions and combinations of conditions should be monitored
regionally or internationally, this study pleads for the assessment of a large but also reasoned
list of conditions that independently impact mortality, disability, or perceived health. This
requirement for an independent impact on health enables us to move beyond the debate about
which type of condition (risk factors, symptoms, syndromes, diseases) should be considered in
the multimorbidity assessment [37]: Any chronic or recurrent condition found in the current
nosology (as reflected in the International Classification of Diseases, which includes diseases
and sometimes syndromes and symptoms) with an independent impact on health should be
considered as long as its frequency in the community justifies its monitoring. The magnitude
of the impact may be considered among the prioritization criteria in order to limit the list.
Multimorbid potential of conditions and meanings of the combinations
This study confirmed that several conditions have a high “multimorbid potential,” i.e., a high
possibility of being associated with other conditions, which is notably the case with vasculome-
tabolic and musculoskeletal conditions, chronic obstructive pulmonary disease, and especially
mental disorders. These conditions were found in many dyads and triads in line with those
retrieved by Prados-Torres and colleagues [9] and Violan and colleagues [8]. This suggests
that interventions aimed at reducing the incidence of conditions with a high multimorbid
potential could be an effective way to alleviate the burden of multimorbidity, which should
thus be prioritized. On the contrary, as already reported [38], most cancers, multiple sclerosis,
and dementia occur in a more isolated manner, although the underdiagnosis or underreport-
ing of comorbid conditions cannot be excluded, in particular for dementia. One of the original
aspects of this study, however, was the analysis of more than 200 dyads in terms of plausible
etiological pathways. Using the typology of Valderas and colleagues [10], this analysis gave
meaning to the combinations of conditions and provides clues for their clinical management
beyond the simple mechanism of complication, which only drives a part of them. In particular,
associations probably driven by bidirectional causality are especially important in the clinical
setting if one condition is more treatable than another as in the case of depression and low
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back pain. Associations that share the same risk factors also require attention, as these factors
may be more easily detected and tackled in multimorbid participants. In this regard, the major
(and often causal) role played by obesity, depression, and anxiety in many associations, either
as a component or as a shared risk factor of the components, should be stressed, especially as
these conditions are not considered or are even excluded in several multimorbidity studies
[39,40].
Impact and joint effects of multimorbid associations
This study is one of the first to analytically address the impact and joint effects of a large num-
ber of multimorbid associations on activity limitations and perceived heath. These different
but related aspects largely determine the potential severity of the multimorbid associations. As
they directly reflect the burden experienced by the participants, the impact of multimorbid
associations on health indicators is best investigated and reported in terms of absolute risks.
Diseases with complications have the greatest impact on health, but associations of conditions
that affect different systems also appear to have large impacts. Associations concerning systems
involved in locomotion (cardiovascular, respiratory, osteoarticular), and to a lesser extent,
those affecting sensorial functions strongly impact both activity limitations and perceived
health, whereas associations with mental disorders mostly impact perceived health. The highly
different impacts resulting from the association of 2, 3, or even 4 conditions, which form the
bulk of the multimorbidity burden, make the simple counting of conditions inadequate in
order to characterize the burden of multimorbidity. This inadequacy has recently been pointed
out with regard to the impact on mortality [30,33,41].
The joint effects and especially the interactions of the components of associations, which
are more closely related to biological mechanisms and synergy phenomena [42], probably
deserve closer attention. In this study, interactions appeared to be extremely variable on a con-
tinuum from subadditive to supermultiplicative. The associations with multiplicative or super-
multiplicative interactions, which included obesity, chronic obstructive pulmonary disease,
migraine, and certain osteoarticular pathologies (inflammatory arthritis and osteoarthritis),
were the most deleterious in terms of joint effects. By contrast, associations involving cardio-
metabolic conditions, low back pain, osteoporosis, injury sequelae, depression, and anxiety
were less unfavorable for this effect. These results have important implications for multimor-
bidity measurements: The variable impacts and joint effects of associations would seem to pre-
clude the exclusive use of a raw count of conditions to quantify multimorbidity.
Strengths and limitations of the study
The strengths of this study include the use of 2 large and nationally representative surveys,
including both cross-sectional and longitudinal data on 60 chronic or recurrent conditions
and 6 health status measures, and the use of a multistep, systematic, and analytical approach to
estimate the impact and the joint effects of conditions on health and to assess the underlying
mechanisms explaining multimorbid associations. Moreover, the convergence and consistency
of results across surveys, health indicators, and time frames further supports the robustness of
our results, which was of particular importance due the type I statistical error that inevitably
plagues the study of numerous morbidities.
This study also has some limitations. First, despite the relatively high levels of participation
and follow-up rates achieved in the 2 nationwide surveys considered here, various marginal
population groups (particularly severely ill participants) may have been underrepresented,
thus limiting the external validity of the study. Second, self-reported information on chronic
or recurrent conditions could be subject to an information bias due to social desirability
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(especially mental health conditions), age, and selective recall (symptom-based conditions are
reported more frequently in surveys [43]). For many of the studied conditions, frequencies
(1-year or lifetime frame) were similar to estimates from previous studies conducted in France
except for obesity (when compared to studies where height and weight were measured [44]),
and for conditions requiring institutionalization such as dementia or schizophrenia, which
were less prevalent than expected. Underestimation of weight may represent a serious problem
in terms of the control of confounding factors, since obesity is involved in many multimorbid
associations. In other conditions, we presume that these biases mostly had a nondifferential
effect on health indicators, possibly with the exception of the impact of disease severity on
recall, as more severe conditions were more likely to be recalled and associated with poorer
health status (severity was not directly assessed in this study, as in most others conducted to
date on multimorbidity [21,45]). However, a lack of sensitivity in the reported information is
preferable to a lack of specificity in terms of the nondifferential misclassification bias observed
in association studies [46]. Third, the implementation of the approach to investigating the etio-
logical pathways underlying multimorbid associations, using the typology proposed by Val-
deras and colleagues [10], suffers from several limitations: The empirical analyses used to
classify into “chance only” and “confounding” categories may have been vulnerable to incom-
plete data (unrecorded conditions), to the cross-sectional nature of part of them, and some-
times to the lack of power; and the literature searching reflects the current knowledge, limited
as regards causal associations between many conditions. Formal mediation analyses would
have been preferable but were far from being achievable in, and also beyond the scope of, this
study. Fourth, this study refrained from using data reduction methods such as factor or cluster
analyses to investigate disease clustering into “patterns.” The implementation of these methods
raises various problems, many of which still need to be resolved [47]. The consideration of dis-
ease combinations in dyads/triads/tetrads, as undertaken in this study, actually addressed pat-
terns in three-quarters of multimorbid participants and also shed light on the process of
morbidity aggregation (multimorbidity first involves two conditions, then three, then four,
and so on). Fifth, unmeasured or incompletely controlled biological confounding cannot be
excluded. Indeed, control for confounding is necessary when considering interactions [48].
The implications of this unquantifiable confounding would be primarily an attenuation of the
associations. Finally, despite the large sample size, the power was limited to detecting small
effects associated with less frequent conditions or even moderate effects in longitudinal analy-
ses. The study of mortality was clearly underpowered due to the low number of deaths
observed in the ESPS survey.
Policy and research implications
The lack of methodological consensus or consistent approaches for studying multimorbidity
has been a serious impediment for the development of appropriate control and prevention
strategies. The proposed approach reported in this paper can guide future contributions with
the aim to gain a better understanding and awareness of the different aspects of multimorbid-
ity. Although undertaken in a single country (France), this study is replicable, as exemplified
by the use of several survey datasets. It could therefore be readily implemented in many coun-
tries with existing systems for the surveillance of chronic diseases.
Multimorbidity is definitely not only a problem of old age; identification and monitoring
should be implemented as early as midlife, possibly earlier in disadvantaged groups. Multimor-
bidity assessments should rapidly move beyond the simple counting of chronic conditions of
any kind by including dozens of chronic conditions that impact health and taking into account
variable impacts and joint effects of component conditions (e.g., monitoring the most frequent
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and impacting dyads or triads). Approaches to reduce the incidence of these combinations
and minimize their impact should also be a priority for improving the health of multimorbid
participants and reducing their impact on healthcare resources.
Further research is needed to evaluate the influence of the data collection method (self-
reports, medical records, administrative data) and the comprehensiveness of data sources on
medical conditions, which should definitely include obesity and mental disorders. Longitudi-
nal studies of trajectories of multimorbid aggregations according to age, sex, and socioeco-
nomic status and their impacts are also required, along with fundamental and clinical research
on pathological interactions, notably between somatic and mental disorders. The clinical
implications of the (statistical) concept of the interaction continuum from subadditive to
supermultiplicative should be scrutinized. Without much delay, however, multimorbid combi-
nations with large health impacts and most deleterious interactions should be appropriately
monitored and managed within the healthcare system.
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